$OCGN filed an 8-K with results (Item 2.02) at 8:28 AM ET on Wed, Nov 4.
Vote
OCGN
Ocugen, Inc.$0.8220CS band Weak
+0.08 (+10.31%) At close · Today 11:55 AM ET
About OCGN
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Why it moved
Moved with Biotech peers: VCEL +8.96% · MRNA +8.23% · DNLI +7.11%
From market data · Not investment advice
Why it moved
Moved with Biotech peers: VCEL +8.96% · MRNA +8.23% · DNLI +7.11%
From market data: the larger companies in its group moved the same way. No report names a cause yet.
Last check 11:30 AM ET
From market data · Not investment adviceSign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
Votes and Bull · Bear posts, 24h. At least 5 are needed.
How do you feel about OCGN?
Board · 0 threads
Open board ›Community opinions, not advice. Posts with a target get a receipt. How receipts work ›